Jefferies Group LLC Roivant Sciences Ltd. Transaction History
Jefferies Group LLC
- $10.2 Billion
- Q3 2022
A detailed history of Jefferies Group LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Jefferies Group LLC holds 42,400 shares of ROIV stock, worth $442,656. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,400Holding current value
$442,656% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$687 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$648 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$499 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$460 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$369 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.35B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...